Analyst Expectations for Coya Therapeutics's Future
Portfolio Pulse from Benzinga Insights
Coya Therapeutics (NASDAQ:COYA) has received 8 bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for the company, according to these analysts, is $19.75, marking a 97.5% increase over the past month.
July 17, 2023 | 9:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Coya Therapeutics has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment. In this case, the bullish ratings and increased price target for Coya Therapeutics could lead to increased investor confidence and buying activity, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100